Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

Journal of Neuroscience

Volumn 16, Issue 1, 1996, Pages 19-30

  Akbarian, S ^a   Sucher, N J ^b   Bradley, D ^a   Tafazzoli, A ^a   Trinh, D ^a   Hetrick, W P ^a   Potkin, S G ^a   Sandman, C A ^a   Bunney Jr , W E ^a   Jones, E G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cerebellum; excitatory amino acid receptors; frontal lobe; glutamate; human association cortex; temporal lobe

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ARTICLE; CONTROLLED STUDY; FRONTAL LOBE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHIZOPHRENIA; TEMPORAL LOBE; TISSUE DISTRIBUTION;

EID: 9044247065     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-01-00019.1996     Document Type: Article

References (70)

1. Akazawa C, Shigemoto R, Bessho Y, Nakanishi S, Mizuno N (1994) Differential expression of five N-methyl-D-aspartate receptor mRNA in the cerebellum of developing and adult rats. J Comp Neurol 347:150-160.
2. Akbarian S, Bunney WE Jr, Potkin SG, Wigal SB, Hagman JO, Sandman CA, Jones EG (1993a) Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 50:169-177.
3. Akbarian S, Viñuela A, Kim JJ, Potkin SG, Bunney WE Jr, Jones EG (1993b) Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 50:178-187.
4. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoh A, Bunney WE Jr, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
5. Andreasen NC, Rezai K, Alliger R, Swayze VW II, Flaum M, Kirchner P, Cohen G, O'Leary DS (1992) Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49:943-958.
6. Armstrong-James M, Fox K (1988) The physiology of developing cortical neurons. In: Cerebral cortex, Vol 7, Development and maturation of cerebral cortex (Peters A, Jones EG, eds), pp 237-272. New York: Plenum.
7. 2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm 85:19-29.
8. A receptor binding activity in prefrontal cortex of schizophrenic brain. Soc Neurosci Abstr 23:8.
9. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924-929.
10. Bennett A, Abi-Saab D, Karper L, D'Souza DC, Abi-Dargham A, Charney D, Krystal J (1995) Ketamine impairs learning, but not procedural expression, on the Wisconsin card sorting test. Schizophr Res 15:108.
11. Bockers TM, Zimmer M, Muller A, Bergmann M, Brose N, Kreutz MR (1994) Expression of the NMDA R1 receptor in selected human brain regions. NeuroReport 5:965-969.
12. Breier A, Malhotra A, Pinals A, Chung I-W, Hidary J, Su T-P, Hsiao J, Pickar D (1995) Neuroanatomical localization of NMDA receptor-mediated psychosis in healthy controls and schizophrenic patients. Schizophr Res 15:77.
13. Brodmann K (1909) Vergleichende Lokalisationslehre der Grosshirnrinde auf Grund des Zellenbaues. Leipzig: Barth.
14. Brose N, Gasic GP, Vetter DE, Sullivan JM, Heinemann SF (1993) Protein chemical characterization and immunocytochemical localization of the NMDA receptor subunit NMDA R1. J Biol Chem 268:22663-22671.
15. Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R (1993) Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 34:529-535.
16. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM (1984) Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorder. Arch Gen Psychiatry 41:1159-1166.
17. Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT (1994) The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. J Neurosci 14:5471-5484.
18. Bunney BG, Bunney WE Jr, Carlsson A (1995) Schizophrenia and glutamate. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 1205-1214. New York: Raven.
19. Carlsson M, Carlsson A (1990) Schizophrenia: a subcortical neurotransmitter imbalance syndrome. Schizophr Bull 16:425-432.
20. Deakin JFW, Simpson MDC, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ (1989) Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52:1781-1786.
21. Dupont J-L, Gardette R, Crepel F (1987) Postnatal development of the chemosensitivity of rat cerebellar Purkinje cells to excitatory amino acids. An in vitro study. Dev Brain Res 34:59-68.
22. Farrant M, Feldmeyer D, Takahashi T, Cull-Candy SG (1994) NMDA-receptor channel diversity in the developing cerebellum. Nature 368:335-339.
23. Fitzgerald LW, Deutch AY, Gasic G, Heinemann SF, Nestler EJ (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
24. Fuster JM (1985) The prefrontal cortex and temporal integration. In: Cerebral cortex, Vol 4, Association and auditory cortices (Peters A, Jones EG, eds), pp 1-61. New York: Plenum.
25. Garthwaite G, Yamini B Jr, Garthwaite J (1987) Selective loss of Purkinje and granule cell responsiveness to N-methyl-D-aspartate in rat cerebellum during development. Dev Brain Res 36:288-292.
26. Glantz LA, Lewis DA (1994) Decreased synaptophysin immunoreactivity in prefrontal cortex of schizophrenics. Biol Psychiatry 35:717.
27. Goldman-Rakic PS (1995) Cellular basis of working memory. Neuron 14:477-485.
28. Hestrin S (1992) Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse. Nature 357:686-689.
29. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
30. Huntley GW, Vickers JC, Janssen W, Brose N, Heinemann SF, Morrison JH (1994) Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human. J Neurosci 14:3603-3619.
31. Hyde TM, Ziegler JC, Weinberger DR (1992) Psychiatric disturbances in metachromatic leukodystrophy: insights into the neurobiology of psychosis. Arch Neurol 49:401-406.
32. Ingvar DH, Franzen G (1974) Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 50:425-462.
33. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi C, Akazawa R, Shigemoto R, Mizuno N, Nakinishi S (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843.
34. Ishimaru M, Kurumaji A, Toru M (1994) Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis. Biol Psychiatry 35:84-95.
35. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
36. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J-P (1994) Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151:1234-1236.
37. Johnson AW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529-531.
38. Jones EG, Hendry SHC, Liu XB, Potkin SG, Tourtellotte WW (1992) A method for fixation of previously fresh frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J Neurosci Methods 44:133-144.
39. Kerwin R, Patel S, Meldrum B (1990) Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39:25-32.
40. Kleinschmidt A, Bear MF, Singer W (1987) Blockade of NMDA receptors disrupts experience-dependent modifications in kitten striate cortex. Science 238:355-358.
41. Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg PH (1994) NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12:1031-1040.
42. 3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients. J Neural Transm 77:231-236.
43. Krystal JH, Karger LP, Seibyl JP, Freeman G, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
44. Kumar KN, Tilakaratne N, Johnson PS, Allen AE, Michaelis EK (1991) Cloning of a cDNA for the glutamate-binding subunit of an NMDA receptor. Nature 354:70-73.
45. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
46. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE (1993) Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch Gen Psychiatry 50:810-818.
47. Le Bourdelles B, Wafford KA, Kemp JA, Marshall G, Bain C, Wilcox AS, Sikela JM, Whiting PJ (1994) Cloning, functional coexpression, and pharmacological characterization of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. J Neurochem 62:2091-2098.
48. Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S (1994) Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76:427-437.
49. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS-R (1959) Study of a new schizophrenomimetic drug-Sernyl. Arch Neurol Psychiatry 119:61-65.
50. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994) Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
51. Monyer H, Sprengel R, Schoepfer A, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1992) Heteromeric NMDA receptors: molecular and functional distribution of subtypes. Science 256:1217-1221.
52. Olney JW (1989) Excitatory amino acid and neuropsychiatric disorders. Biol Psychiatry 26:505-525.
53. Petralia RS, Wang Y-X, Wenthold RJ (1994a) The NMDA receptor subunits, NR2A and NR2B, show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci 14:6102-6120.
54. Petralia RS, Yokotani N, Wenthold RJ (1994b) Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
55. Potkin SG, Costa J, Roy S, Sramck J, Jin Y, Gulasekaram B (1992) Glycine in the treatment of schizophrenia: theory and preliminary results. In: Novel antipsychotic drugs (Meltzer HY, ed), pp 179-188. New York: Raven.
56. Preuss TM, Goldman-Rakic PS (1991) Myelo- and cytoarchitecture of the granular frontal cortex and surrounding regions in the strepsirhine primate Galago and the anthropoid primate Macaca. J Comp Neurol 310:429-474.
57. Rosse RB, Theut SK, Banay-Schwartz M, Leighton M, Scarcella E, Cohen CG, Deutsch SI (1989) Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot study. Clin Neuropharmacol 12:416-424.
58. Schlaggar BL, Fox K, O'Leary DDM (1993) Postsynaptic control of plasticity in developing somatosensory cortex. Nature 364:623-626
59. Selemon LD, Rajkowska G, Goldman-Rakic PS (1993) Cytologic abnormalities in area 9 of the schizophrenic cortex. Soc Neurosci Abstr 19:200.
60. Simpson MD, Slater P, Royston MC, Deakin JF (1991) Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication. Schizophr Res 6:41-48.
61. Sucher NJ, Brose N, Deitcher DL, Awobuluyi M, Gasic GP, Bading H, Cepko CL, Greenberg ME, Jahn R, Heinemann SF, Lipton SA (1993) Expression of endogenous NMDAR1 transcripts without receptor protein suggests post-transcriptional control in PC12 cells. J Biol Chem 268:22299-22304.
62. Sugihara H, Moriyoshi K, Ishii T, Masu M, Nakanishi S (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem Biophys Res Commun 185:826-832.
63. Sullivan JM, Traynelis SF, Chen HSV, Escobar W, Heinemann SF, Lipton SA (1994) Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13:929-936.
64. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 49:522-530.
65. Tatsuoka M (1988) Multivariate analysis of variance: technique for educational and psychological research, 2nd ed. New York: MacMillan.
66. Ulas J, Cotman CW (1993) Excitatory amino acid receptors in schizophrenia. Schizophr Bull 19:105-117.
67. Watanabe M, Inoue Y, Sakimura K, Mishina M (1993) Distinct distributions of five N-methyl-D-aspartate receptor channel subunit mRNA in the forebrain. J Comp Neurol 338:377-390.
68. Waziri R (1988) Glycine therapy of schizophrenia. Biol Psychiatry 23:210-211.
69. Weinberger DR, Berman KF, Zec RF (1986) Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 43:114-125.
70. Zec RF, Weinberger DR (1986) Brain areas implicated in schizophrenia: a selective overview. In: The handbook of schizophrenia, Vol 1, The neurology of schizophrenia (Nasrallah HA, Weinberger DR, eds), pp 175-206. Amsterdam: Elsevier Science.